Published in Clin Endocrinol (Oxf) on February 01, 2005
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid (2010) 2.48
Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ (2007) 2.28
Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg (2007) 2.04
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev (2009) 1.78
A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid (2009) 1.62
Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. Am J Epidemiol (2007) 1.58
Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol (2011) 1.54
Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid (2013) 1.46
BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One (2012) 1.39
Mortality-related factors in 1056 radioiodine-treated patients with well-differentiated thyroid cancer in southern Thailand. World J Surg (2010) 1.38
Increasing thyroid cancer incidence in Lithuania in 1978-2003. BMC Cancer (2006) 1.22
The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab (2010) 1.22
Contralateral papillary thyroid cancer: does size matter? Am J Surg (2009) 1.14
Increasing detection and increasing incidence in thyroid cancer. World J Surg (2009) 1.09
Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid (2013) 1.01
Canadian adolescents and young adults with cancer: opportunity to improve coordination and level of care. CMAJ (2011) 1.01
Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors. Thyroid (2013) 0.99
The changing incidence of thyroid cancer. Nat Rev Endocrinol (2016) 0.96
Synchronous and antecedent nonthyroidal malignancies in patients with papillary thyroid carcinoma. J Am Coll Surg (2013) 0.92
Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers. Ann Surg (2007) 0.92
The changing face of thyroid cancer in a population-based cohort. Cancer Med (2013) 0.91
Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006. Eur Arch Otorhinolaryngol (2010) 0.90
The Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades. Endocrinol Metab (Seoul) (2014) 0.89
Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update. Radiat Res (2010) 0.85
Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res (2015) 0.84
The association between the socioeconomic status and thyroid cancer prevalence; based on the Korean National Health and Nutrition Examination Survey 2010-2011. J Korean Med Sci (2013) 0.82
Incidence of differentiated thyroid cancer in Canada by City of residence. J Otolaryngol Head Neck Surg (2015) 0.81
The geographical pattern of thyroid cancer mortality between 1980 and 2009 in Italy. Thyroid (2013) 0.80
Surgical options in undifferentiated thyroid carcinoma. World J Surg (2007) 0.80
Sonographic detection of thyroid cancer in breast cancer patients. Yonsei Med J (2007) 0.79
Thyroid cancer detected by mass screening over a period of 16 years at a health care center in Japan. Surg Today (2006) 0.78
Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer (2015) 0.77
Association between Hashimoto's Thyroiditis and Thyroid Cancer in 64,628 Patients. Front Oncol (2017) 0.75
Predicting malignancy in thyroid nodules: feasibility of a predictive model integrating clinical, biochemical, and ultrasound characteristics. Thyroid Res (2016) 0.75
Causes of referral to the first endocrine visit of patients with thyroid carcinoma in a mildly iodine-deficient area. Endocrine (2016) 0.75
Changing patterns in thyroid cancer incidence and mortality in the Slovak Republic by histological type and age. Int J Clin Oncol (2013) 0.75
The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol (2004) 2.02
Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care (2006) 1.63
Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control (2007) 1.61
National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol (2003) 1.56
Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab (2006) 1.54
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2011) 1.46
Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer (2008) 1.44
Improved treatment and survival for lung cancer patients in South-East Scotland. J Thorac Oncol (2008) 1.43
Risk of second cancer among women with breast cancer. Int J Cancer (2006) 1.41
The Adolescent Intensive Management Team: an intensive outreach mental health service for high-risk adolescents. Australas Psychiatry (2008) 1.39
Recurrent dizzy spells: all in the head! Ann Clin Biochem (2005) 1.39
Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers. J Clin Oncol (2010) 1.34
Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst (2007) 1.34
Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2009) 1.34
Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer (2007) 1.32
Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2010) 1.32
The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord (2008) 1.30
Is the Scottish population living dangerously? Prevalence of multiple risk factors: the Scottish Health Survey 2003. BMC Public Health (2010) 1.20
Oropharyngeal cancer. Fastest increasing cancer in Scotland, especially in men. BMJ (2010) 1.20
Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev (2008) 1.18
Ascertainment of breast cancer by the Scottish Cancer Registry: an assessment based on comparison with five independent breast cancer trials databases. Breast (2007) 1.12
Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study. J Clin Endocrinol Metab (2010) 1.11
Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer (2006) 1.10
Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries. Int J Cancer (2007) 1.09
Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer (2007) 1.05
Rectal cancer survival in the Nordic countries and Scotland. Int J Cancer (2009) 1.04
Diabetes, cognitive impairment, and dementia. BMJ (2008) 1.03
Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium. PLoS One (2013) 1.02
Commentary: long-term monitoring of health inequalities in Scotland--a response to Frank and Haw. Milbank Q (2013) 1.00
Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends. Cancer Epidemiol (2012) 1.00
Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health (2011) 0.99
Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care (2013) 0.99
Changing trends in incidence of lung cancer by histologic type in Scotland. Int J Cancer (2002) 0.98
Variation in the uric acid transporter gene (SLC2A9) and memory performance. Hum Mol Genet (2010) 0.97
Risk of breast cancer after miscarriage or induced abortion: a Scottish record linkage case-control study. J Epidemiol Community Health (2005) 0.96
Home blood glucose monitoring in type 2 diabetes. BMJ (2004) 0.95
Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. Radiother Oncol (2009) 0.95
A pooled analysis of second primary pancreatic cancer. Am J Epidemiol (2006) 0.94
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study. J Hepatol (2013) 0.94
Does the 'Scottish effect' apply to all ethnic groups? All-cancer, lung, colorectal, breast and prostate cancer in the Scottish Health and Ethnicity Linkage Cohort Study. BMJ Open (2012) 0.93
Radioiodine treatment of hyperthyroidism. BMJ (2007) 0.92
Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2013) 0.91
Cohort profile: Scottish health and ethnicity linkage study of 4.65 million people exploring ethnic variations in disease in Scotland. Int J Epidemiol (2010) 0.91
Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors. Kidney Int (2012) 0.90
Genetic variants associated with altered plasma levels of C-reactive protein are not associated with late-life cognitive ability in four Scottish samples. Behav Genet (2009) 0.90
Socioeconomic inequalities in incidence of lung and upper aero-digestive tract cancer by age, tumour subtype and sex: a population-based study in Scotland (2000-2007). Cancer Epidemiol (2012) 0.89
Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? No. BMJ (2011) 0.89
Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care (2010) 0.88
Mutations in HNF1A result in marked alterations of plasma glycan profile. Diabetes (2012) 0.87
Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference. Ann Clin Biochem (2013) 0.86
Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy. Eur J Cancer (2010) 0.86
Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 diabetes study. J Hypertens (2013) 0.86
Serum leptin and cognitive function in people with type 2 diabetes. Neurobiol Aging (2012) 0.85
Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes. PLoS One (2012) 0.84
Cardiovascular disease and air pollution in Scotland: no association or insufficient data and study design? BMC Public Health (2012) 0.83
Leptin levels and depressive symptoms in people with type 2 diabetes: the edinburgh type 2 diabetes study. Psychosom Med (2011) 0.82
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes. Diabetologia (2015) 0.82
Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol (2012) 0.81
Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts. Behav Genet (2011) 0.81
Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States. Eur J Cancer (2010) 0.81
Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2013) 0.81
Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes. Diabetes Care (2013) 0.79
Risk of skin cancer after neonatal phototherapy: retrospective cohort study. Arch Dis Child (2010) 0.79
γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study. Diabetologia (2015) 0.79
High constant incidence rates of second primary cancers of the head and neck: a pooled analysis of 13 cancer registries. Int J Cancer (2010) 0.79
Associations between ocular melanoma and other primary cancers: an international population-based study. Int J Cancer (2007) 0.78
Beware using secular trends in deaths to judge effectiveness of breast screening. BMJ (2013) 0.78
Declining breast cancer incidence and decreased HRT use. Lancet (2009) 0.78
N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia (2014) 0.78
Left-sided excess in the laterality of cutaneous melanoma. Arch Dermatol (2008) 0.77
Left-sided excess of invasive cutaneous melanoma. J Am Acad Dermatol (2011) 0.77
Introduction. IARC Sci Publ (2014) 0.76
Estrogen biosynthesis in human H295 adrenocortical carcinoma cells. Mol Cell Endocrinol (2008) 0.76
Second malignancies after childhood noncentral nervous system solid cancer: Results from 13 cancer registries. Int J Cancer (2011) 0.76
Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study. Eur J Endocrinol (2012) 0.75
UK cancer survival statistics. Survival is multifactorial. BMJ (2010) 0.75
Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data. HPB (Oxford) (2012) 0.75
Absence of sexual dimorphism in the symptomatic responses to hypoglycemia in adults with and without type 1 diabetes. Diabetes Care (2006) 0.75
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Liver Int (2013) 0.75
Second primary malignancies among women with uterine sarcoma. Gynecol Oncol (2012) 0.75
Second primary malignancies in females with primary fallopian tube cancer. Int J Cancer (2007) 0.75
Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation. Int J Cancer (2009) 0.75